ELVN

Enliven Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$38.83

Market Cap

$2.32B

Beta

0.49

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)+3.17%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-3.03%

Debt / Equity0.00

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for ELVN.